Contents
THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007note, and in particular Article 75(2), thereof,Whereas:
(1)Commission Delegated Regulation (EU) 2022/2104note lays down rules on the characteristics of the olive oils referred to in Part VIII, points 1 to 6, of Annex VII to Regulation (EU) No 1308/2013.
(2)The limit values for the characteristics of olive oil laid down in Delegated Regulation (EU) 2022/2104 reflect the trade standard for olive oil and olive-pomace oil of the International Olive Council (IOC)note (hereinafter, ‘IOC Trade Standard’).
(3)At its 116th IOC session which took place on 30 November 2022, the IOC adopted Decision DEC-III.2/116-VI/2022 amending the IOC Trade Standard as regards the limit of Δ-7-stigmastenol for all categories of olive oil. The Union voted in favour of this amendment, in accordance with Council Decision (EU) 2022/2391note.
(4)In order to ensure the implementation at Union level of the most recent international standard on limit values for the parameter Δ-7-stigmastenol established by the IOC, Delegated Regulation (EU) 2022/2104 should be amended accordingly,
HAS ADOPTED THIS REGULATION:
Article 1#
Delegated Regulation (EU) 2022/2104 is amended as follows:
(1)Annex I is amended as follows:
(a)table B is replaced by the table set out in Annex I to this Regulation;
(b)its Appendix is deleted;
(2)Annex III is replaced by the text set out in Annex II to this Regulation.
Article 2#
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Annex I
‘B.Purity characteristicsCategory | Fatty acid composition | Total transoleic isomers(%) | Total trans- linoleic + trans-linolenic isomers(%) | Stigmasta- dienes(mg/kg) | ΔΕCN42 | 2-glyceryl monopalmitate(%)Myristic(%) | Linolenic(%) | Arachidic(%) | Eicosenoic(%) | Behenic(%) | Lignoceric(%)1.Extra virgin olive oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,20 | ≤ 0,20 | ≤ 0,05 | ≤ 0,05 | ≤ 0,05 | ≤ |0,20| | ≤ 0,9 if total palmitic acid % ≤ 14,00 %≤ 1,0 if total palmitic acid % > 14,00 %2.Virgin olive oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,20 | ≤ 0,20 | ≤ 0,05 | ≤ 0,05 | ≤ 0,05 | ≤ |0,20| | ≤ 0,9 if total palmitic acid % ≤ 14,00 %≤ 1,0 if total palmitic acid % > 14,00 %3.Lampante olive oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,20 | ≤ 0,20 | ≤ 0,10 | ≤ 0,10 | ≤ 0,50 | ≤ |0,30| | ≤ 0,9 if total palmitic acid % ≤ 14,00 %≤ 1,1 if total palmitic acid % > 14,00 %4.Refined olive oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,20 | ≤ 0,20 | ≤ 0,20 | ≤ 0,30 | — | ≤ |0,30| | ≤ 0,9 if total palmitic acid % ≤ 14,00 %≤ 1,1 if total palmitic acid% > 14,00 %5.Olive oil composed of refined olive oil and virgin olive oils | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,20 | ≤ 0,20 | ≤ 0,20 | ≤ 0,30 | — | ≤ |0,30| | ≤ 0,9 if total palmitic acid% ≤ 14,00 %≤ 1,0 if total palmitic acid% > 14,00 %6.Crude olive-pomace oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,30 | ≤ 0,20 | ≤ 0,20 | ≤ 0,10 | — | ≤ |0,60| | ≤ 1,47.Refined olive-pomace oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,30 | ≤ 0,20 | ≤ 0,40 | ≤ 0,35 | — | ≤ |0,50| | ≤ 1,48.Olive-pomace oil | ≤ 0,03 | ≤ 1,00 | ≤ 0,60 | ≤ 0,50 | ≤ 0,30 | ≤ 0,20 | ≤ 0,40 | ≤ 0,35 | — | ≤ |0,50| | ≤ 1,2Table B continuedCategory | Sterols composition | Total sterols(mg/kg) | Erythrodiol and uvaol (**) (%) | Waxes (**) (mg/kg)Chole-sterol (%) | Brassica-sterol (%) | Campe-sterol(%) | Stigmasterol (%) | Apparent β–sito-sterol (%) | Δ-7-stigma-stenol (%)1.Extra virgin olive oil | ≤ 0,5 | ≤ 0,1 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1000 | ≤ 4,5 | C42 + C44 + C46 ≤ 1502.Virgin olive oil | ≤ 0,5 | ≤ 0,1 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1000 | ≤ 4,5 | C42 + C44 + C46 ≤ 1503.Lampante olive oil | ≤ 0,5 | ≤ 0,1 | ≤ 4,0 | — | ≥ 93,0 | ≤ 0,5 | ≥ 1000 | ≤ 4,5 | C40 + C42 + C44 + C46 ≤ 3004.Refined olive oil | ≤ 0,5 | ≤ 0,1 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1000 | ≤ 4,5 | C40 + C42 + C44 + C46 ≤ 3505.Olive oil composed of refined olive oil and virgin olive oils | ≤ 0,5 | ≤ 0,1 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1000 | ≤ 4,5 | C40 + C42 + C44 + C46 ≤ 3506.Crude olive-pomace oil | ≤ 0,5 | ≤ 0,2 | ≤ 4,0 | — | ≥ 93,0 | ≤ 0,5 | ≥ 2500 | > 4,5 | C40 + C42 + C44 + C46 > 3507.Refined olive-pomace oil | ≤ 0,5 | ≤ 0,2 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1800 | > 4,5 | C40 + C42 + C44 + C46 > 3508.Olive-pomace oil | ≤ 0,5 | ≤ 0,2 | ≤ 4,0 | < Camp. | ≥ 93,0 | ≤ 0,5 | ≥ 1600 | > 4,5 | C40 + C42 + C44 + C46 > 350Notes:
(a)The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4.
(b)If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation.
(c)For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category.
(d)If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’
Annex II
‘’
III · Correlation table
| Implementing Regulation (EU) No 29/2012 | Regulation (EEC) No 2568/91 | This Regulation | Implementing Regulation (EU) 2022/2105 |
|---|---|---|---|
| — | — | Article 1, point (a) | |
| — | — | Article 1 | |
| — | — | Article 2(2) | |
| Article 1(1) | Article 1, point (b), and Article 1(2) | ||
| Article 1(2) | Article 1, point (b) | ||
| Article 2, first paragraph | Article 4(1) | ||
| Article 2, second paragraph | Article 4(2) | ||
| Article 3, first paragraph | Article 6(1) | ||
| Article 3, second paragraph, points (a) to (d) | Article 6(2), points (a) to (d) | ||
| Article 4(1), first subparagraph | Article 8(1) | ||
| Article 4(1), second subparagraph | Article 8(2) | ||
| Article 4(1), third subparagraph | — | ||
| Article 4(2) | Article 8(3) | ||
| Article 4(3) | Article 8(4) | ||
| Article 4(4) | Article 8(5) | ||
| Article 4(5), first subparagraph | Article 8(6) | ||
| Article 4(5), second subparagraph | Article 8(7) | ||
| Article 4a | Article 7 | ||
| Article 4b | Article 5 | ||
| Article 5, first paragraph, points (a) to (d) | Article 10, points (a) to (d) | ||
| Article 5, first paragraph, point (e) | Article 11(1) and (2) | ||
| Article 5, second paragraph | — | ||
| Article 5a, first paragraph | Article 11(3) | ||
| Article 5a, second paragraph | Article 11(4) | ||
| Article 5a, third paragraph | Article 11(5) | ||
| Article 6(1), first subparagraph | Article 12(1) | ||
| Article 6(1), second subparagraph | Article 12(2) | ||
| Article 6(1), third subparagraph | Article 3(3) | ||
| Article 6(2), first subparagraph | Article 12(3) | ||
| Article 6(2), second subparagraph | Article 12(4) | ||
| Article 6(3) | Article 12(5) | ||
| — | — | Article 12(6) | |
| Article 6(4) | — | ||
| Article 7 | Article 5(2) | ||
| Article 8(1) | Article 2(3) | ||
| Article 8(2) | Article 4(3) | ||
| Article 8(3) | Article 4(2) | ||
| Article 8(4) | Article 4(3) | ||
| Article 8a | Article 2(1) and Article 4(1) | ||
| Article 9(1), first subparagraph | Article 13(1) | ||
| Article 9(1), second subparagraph | Article 13(2) | ||
| Article 9(1), third subparagraph | — | ||
| Article 9(1), fourth subparagraph | — | ||
| Article 9(1), fifth subparagraph | — | ||
| Article 9(2),first subparagraph | Article 6(1) | ||
| Article 9(2), second subparagraph, points (a), (b) and (c) | Article 6(2), points (a), (b) and (c) | ||
| Article 9(2), third subparagraph | Article 9 | ||
| — | Article 6(3) | ||
| Article 10, first paragraph, introductory sentence | Article 14 | ||
| Article 10, first paragraph, points (a) to (d), and second paragraph | — | ||
| Article 10a | Article 14 | ||
| Annex I | — | ||
| Annex II | — | ||
| Article 1(1) | Article 2(1), points (a) and (b) | ||
| Article 1(2) | Article 2(1), point (c) | ||
| Article 1(3) | Article 2(1), point (d) | ||
| Article 1(4) | Article 2(1), point (e) | ||
| Article 1(5) | Article 2(1), point (f) | ||
| Article 1(6) | Article 2(1), point (g) | ||
| Article 1(7) | Article 2(1), point (h) | ||
| — | — | Article 2(2) | |
| — | — | Article 3(1) and (2) | |
| Article 2(1) | Article 7 | ||
| Article 2(1), point (a) | Annex I, point 1 | ||
| Article 2(1), point (b) | Annex I, point 2 | ||
| Article 2(1), point (c) | — | ||
| Article 2(1), point (d) | — | ||
| Article 2(1), point (e) | Annex I, point 3 | ||
| Article 2(1), point (f) | Annex I, point 4 | ||
| Article 2(1), point (g) | Annex I, point 6 | ||
| Article 2(1), point (h) | — | ||
| Article 2(1), point (i) | Annex I, point 5 | ||
| Article 2(1), point (j) | Annex I, point 9 | ||
| Article 2(1), point (k) | Annex I, point 10 | ||
| Article 2(1), point (l) | Annex I, point 8 | ||
| Article 2(1), point (m) | Annex I, point 7 | ||
| Article 2(2), first subparagraph and part of point 9.4 of Annex XII | Article 10(1) | ||
| Article 2(2), second subparagraph | Article 11(1) | ||
| Article 2(2), third subparagraph | Article 11(2) | ||
| — | Article 11(3) | ||
| part of point 9.4 of Annex XII | Article 11(4) | ||
| Article 2(3), first subparagraph | Article 3(1) | ||
| Article 2(3), second subparagraph | Article 3(2) | ||
| Article 2(4), first subparagraph | Article 9(2) | ||
| Article 2(4), second subparagraph | Article 9(3) | ||
| Article 2(4), third subparagraph | Article 9(4) | ||
| Article 2(5) | Article 9(5) | ||
| Article 2a(1) | Article 3(1) | ||
| Article 2a(2) | Article 3(3) | ||
| Article 2a(3) | Article 3(4) | ||
| Article 2a(4), first subparagraph | Article 3(5) | ||
| Article 2a(4), second subparagraph | Article 3(2) | ||
| Article 2a(5) | Article 9(1) | ||
| Article 3, first paragraph | Article 13(1) | ||
| Article 3, second paragraph | Article 3(6) | ||
| Article 4(1), first subparagraph | Article 10(1) | ||
| Article 4(1), second subparagraph | Article 10(2) | ||
| Article 4(1), third subparagraph | Article 10(3) | ||
| Article 4(2) | Article 10(4) | ||
| Article 4(3) | - | ||
| Article 6(1) | Article 12(1) | ||
| Article 6(2) | Article 12(2) | ||
| Article 7 | — | ||
| Article 7a, first subparagraph | Article 5(1) | ||
| Article 7a, second paragraph | Article 2(2) | ||
| Article 8(1) | — | ||
| Article 8(2) | Article 14 | ||
| Annex I | Annex I | ||
| Annex XII, point 3.3 | Annex II | ||
| Annex Ia, except for point 2.1 | Annex II | ||
| Annex Ia, point 2.1 | Article 9(6) | ||
| Annex Ib | Annex III | ||
| Annex III | — | ||
| Annex IV | — | ||
| Annex VII | — | ||
| Annex IX | — | ||
| Annex X | — | ||
| Annex XI | — | ||
| Annex XII, except for point 3.3 and part of point 9.4 | — | ||
| Annex XV | Annex IV | ||
| Annex XVI | — | ||
| Annex XVII | — | ||
| Annex XVIII | — | ||
| Annex XIX | — | ||
| Annex XX | — | ||
| Annex XXI | Annex V |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.